课题基金 / 基金详情

Improving Health-related Quality of Life in Patients with Rare Autoimmune Liver Diseases by Structured Peer-derived Support: A Transnational Effectiveness-implementation Hybrid Trial

Improving Health-related Quality of Life in Patients with Rare Autoimmune Liver Diseases by Structured Peer-derived Support: A Transnational Effectiveness-implementation Hybrid Trial
通过结构化同伴支持改善罕见自身免疫性肝病患者的健康相关生活质量：跨国有效性实施混合试验
批准号：
449979
负责人：
Hirschfield Gideon M
金额：
$16.37万
依托单位：
University Health Network (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-06-01 至 2024-06-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=449979&lang=en
关键词：
Effectiveness-Implementation Hybrid Trial Liver Diseases Psychological Adaptation Psychosocial Support Psychosomatic Medicine Quality Of Life Rare Diseases

项目摘要

项目成果

Hirschfield Gideon M的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Rare diseases can negatively affect a patients' quality of life and psychosocial support needs of affected individuals often go unmet. A randomised clinical efficacy trial showed a newly developed, peer-delivered psychosocial support program led to improv
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Dissection of Primary Biliary Cirrhosis
  • 批准号：
    226033
  • 项目类别：
    Operating Grants
  • 资助金额：
    $58.45万
  • 财政年份：
    2011
  • 负责人：
    Hirschfield Gideon M
  • 依托单位：
    Toronto Western Hospital
海外基金